Gd-DTPA as a contrast agent in CT.
- 1 May 1989
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 171 (2) , 578-579
- https://doi.org/10.1148/radiology.171.2.2704827
Abstract
An evaluation was done of the effect of gadolinium diethylenetriaminepentaacetic acid (DTPA) on computed tomographic (CT) studies performed after magnetic resonance (MR) imaging. CT scans of two solutions of Gd-DTPA demonstrated substantial attenuation. In two patients who underwent CT after Gd-DTPA-enhanced MR imaging, the high attenuation of concentrated Gd-DTPA was seen in the urinary bladder and renal collecting system. However, in the concentration presently used in MR imaging, Gd-DTPA results in only minor enhancement of renal cortex.This publication has 5 references indexed in Scilit:
- Brain tumors: MR imaging with gadolinium-DTPA.Radiology, 1985
- Hemodynamic effects of rapid and slow infusions of manganese chloride and gadolinium-DTPA in dogs.Radiology, 1985
- Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.Radiology, 1985
- Intravascular contrast agents suitable for magnetic resonance imaging.Radiology, 1984
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984